Display options
Cite
Yaturu S. Insulin therapies: Current and future trends at dawn. World J Diabetes. 2013;4(1):1-7doi: 10.4239/wjd.v4.i1.1.
Yaturu, S. (2013). Insulin therapies: Current and future trends at dawn. World journal of diabetes, 4(1), 1-7. https://doi.org/10.4239/wjd.v4.i1.1
Yaturu, Subhashini. "Insulin therapies: Current and future trends at dawn." World journal of diabetes vol. 4,1 (2013): 1-7. doi: https://doi.org/10.4239/wjd.v4.i1.1
Yaturu S. Insulin therapies: Current and future trends at dawn. World J Diabetes. 2013 Feb 15;4(1):1-7. doi: 10.4239/wjd.v4.i1.1. PMID: 23493823; PMCID: PMC3596776.
Copy Download .nbib Format: NLM
Share it on

World J Diabetes. 2013 Feb 15;4(1):1-7. doi: 10.4239/wjd.v4.i1.1.

Insulin therapies: Current and future trends at dawn.

World journal of diabetes

Subhashini Yaturu

Affiliations

  1. Subhashini Yaturu, Endocrinology Section, Stratton VA Medical Center, Albany, NY 12208, United States.

PMID: 23493823 PMCID: PMC3596776 DOI: 10.4239/wjd.v4.i1.1

Abstract

Insulin is a key player in the control of hyperglycemia for type 1 diabetes patients and selective individuals in patients of type 2 diabetes. Insulin delivery systems that are currently available for the administration of insulin include insulin syringes, insulin infusion pumps, jet injectors and pens. The traditional and most predictable method for the administration of insulin is by subcutaneous injections. The major drawback of current forms of insulin therapy is their invasive nature. To decrease the suffering, the use of supersonic injectors, infusion pumps, sharp needles and pens has been adopted. Such invasive and intensive techniques have spurred the search for alternative, more acceptable methods for administering insulin. Several non-invasive approaches for insulin delivery are being pursued. The newer methods explored include the artificial pancreas with closed-loop system, transdermal insulin, and buccal, oral and pulmonary routes. This review focuses on the new concepts that are being explored for use in future.

Keywords: Diabetes; Inhaled insulin; Insulin delivery systems; Insulin therapy; Oral insulin; Transdermal insulin

References

  1. Diabetes. 1974 Sep;23(9):732-8 - PubMed
  2. J Pediatr Endocrinol Metab. 1999;12 Suppl 3:751-8 - PubMed
  3. J Diabetes Sci Technol. 2011 May 01;5(3):681-6 - PubMed
  4. Pharmazie. 2001 Mar;56(3):217-9 - PubMed
  5. Pharm Res. 2011 Sep;28(9):2110-8 - PubMed
  6. J Pharm Pharmacol. 2009 Jun;61(6):689-705 - PubMed
  7. Pharm Res. 2012 Aug;29(8):2104-14 - PubMed
  8. Diabetes Obes Metab. 2012 Feb;14(2):163-73 - PubMed
  9. Clin Ther. 2005;27 Suppl B:S89-100 - PubMed
  10. Int J Pharm. 2011 Apr 4;407(1-2):95-104 - PubMed
  11. J Aerosol Med Pulm Drug Deliv. 2011 Oct;24(5):213-23 - PubMed
  12. J Assoc Physicians India. 2011 Apr;59 Suppl:38-40 - PubMed
  13. Int J Clin Pract Suppl. 2011 Feb;(170):26-30 - PubMed
  14. Diabetes Obes Metab. 2010 Aug;12(8):659-64 - PubMed
  15. Int J Pharm. 2002 Dec 5;249(1-2):139-47 - PubMed
  16. Diabetes Obes Metab. 2012 Mar;14(3):222-7 - PubMed
  17. Nanomedicine (Lond). 2011 Oct;6(8):1297-300 - PubMed
  18. J Biomed Mater Res B Appl Biomater. 2009 Jan;88(1):41-8 - PubMed
  19. Expert Opin Drug Deliv. 2006 Jan;3(1):127-38 - PubMed
  20. Biomacromolecules. 2009 May 11;10(5):1253-8 - PubMed
  21. Diabetologia. 2008 Sep;51(9):1602-6 - PubMed
  22. J Biomed Mater Res A. 2007 Nov;83(2):383-90 - PubMed
  23. Diabetes. 2011 Nov;60(11):2672-82 - PubMed
  24. Int J Clin Pract. 2004 Apr;58(4):394-401 - PubMed
  25. J Clin Pharmacol. 2011 Jul;51(7):964-77 - PubMed
  26. Diabetes Care. 2012 Nov;35(11):2174-81 - PubMed
  27. ISRN Pharm. 2011;2011:780150 - PubMed
  28. Diabetes Obes Metab. 2010 Feb;12(2):91-6 - PubMed
  29. Lancet. 2012 Apr 21;379(9825):1465-7 - PubMed
  30. J Pharm Pharmacol. 2012 Jan;64(1):11-29 - PubMed
  31. J Control Release. 2009 Oct 1;139(1):63-72 - PubMed
  32. Diabetologia. 2008 Jun;51(6):941-51 - PubMed
  33. J Pharm Sci. 2002 Jun;91(6):1396-404 - PubMed
  34. AAPS PharmSciTech. 2011 Mar;12(1):10-20 - PubMed
  35. Diabetes Care. 1990 Sep;13(9):923-54 - PubMed
  36. Diabetes Care. 2011 Mar;34(3):661-5 - PubMed
  37. Clin Chem. 2002 Dec;48(12):2270-88 - PubMed
  38. Expert Opin Investig Drugs. 2006 Jul;15(7):743-62 - PubMed
  39. Diabetes Technol Ther. 2007 Jun;9 Suppl 1:S93-S101 - PubMed
  40. Lancet. 1978 Aug 5;2(8084):283-5 - PubMed
  41. J Diabetes Sci Technol. 2009 May 01;3(3):568-84 - PubMed
  42. Colloids Surf B Biointerfaces. 2012 Apr 1;92:175-9 - PubMed
  43. Expert Opin Biol Ther. 2012 May;12(5):539-42 - PubMed
  44. Am J Ther. 2011 Sep;18(5):392-402 - PubMed
  45. Lancet. 2010 Jun 26;375(9733):2244-53 - PubMed
  46. Clin Ther. 2003 Nov;25(11):2836-48 - PubMed
  47. Diabetes Care. 2011 Mar;34(3):666-8 - PubMed
  48. Pharmacol Res. 2002 Nov;46(5):459-67 - PubMed
  49. Lancet. 2012 Apr 21;379(9825):1498-507 - PubMed
  50. Lancet. 2012 Apr 21;379(9825):1489-97 - PubMed
  51. J Diabetes Sci Technol. 2008 Jul;2(4):568-71 - PubMed
  52. Pharmacoeconomics. 2008;26(3):217-34 - PubMed
  53. J Drug Deliv. 2012;2012:750891 - PubMed
  54. J Diabetes Sci Technol. 2009 May 01;3(3):562-7 - PubMed
  55. J Control Release. 2007 Sep 26;122(2):141-50 - PubMed
  56. Indian J Pharmacol. 2012 Jan;44(1):103-5 - PubMed
  57. Curr Drug Deliv. 2012 Jan;9(1):57-73 - PubMed
  58. Acta Diabetol Lat. 1978 Jan-Apr;15(1-2):81-7 - PubMed
  59. Exp Clin Endocrinol Diabetes. 2002 Jan;110(1):17-21 - PubMed
  60. Eur J Pharm Biopharm. 2010 May;75(1):26-32 - PubMed
  61. Lancet. 2011 Mar 12;377(9769):924-31 - PubMed

Publication Types